Professor Keith Martin: Ledger

Stories naming Professor Keith Martin. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.

Role	Organisation	Sources
Co-founder and Medical Director	Mirugen	Brandon BioCatalyst, insightnews.com.au, cera.org.au, mirugen.com
Managing Director (former)	Centre for Eye Research Australia	cera.org.au, Breakthrough Victoria

2 deals

Mirugen Secures A$4.5m to Pioneer Cell (Re)programming, and Welcomes Charlotte Casebourne Stock as Executive Chair

Mirugen, a Melbourne biotech spun out of an eye research institute, has closed a A$4.5m seed round with three backers and hired Charlotte Casebourne Stock as chair and acting chief executive.

mirugen.com 13 Aug 2025 Mirugen Theolytics Brandon BioCatalyst Centre for Eye Research Australia CSIRO CUREator Medical Research Future Fund Tanarra Capital Yarvie Brandon Capital Breakthrough Victoria Tin Alley Ventures University of Melbourne University of Melbourne Genesis Pre-Seed Fund Associate Professor Raymond Wong Charlotte Casebourne Stock Professor Keith Martin Dr Winnie Gao

Also cera.org.au·Brandon BioCatalyst portfolio·insightnews.com.au

Unnamed stage $10m

Investment update: Cerulea

Breakthrough Victoria marks the opening of an eye research facility it backed with $10 million; the CERA-affiliated centre expects to treat thousands of patients and create dozens of jobs.

Breakthrough Victoria 20 May 2024 Cerulea Clinical Trials Centre for Eye Research Australia Breakthrough Victoria John Brumby Professor Keith Martin

Professor Keith Martin

Roles

Coverage

Mirugen Secures A$4.5m to Pioneer Cell (Re)programming, and Welcomes Charlotte Casebourne Stock as Executive Chair

Investment update: Cerulea